Blue Trust’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
Other funds holding IDXX
Blue Trust's IDXX Position: Q3 2026 in Review
Blue Trust reduced its Idexx Laboratories (IDXX) stake by 63% in Q3 2026, selling an estimated $51.5K and leaving 56 shares worth $29.2K. The position accounts for ﹤0.01% of the portfolio, ranked #1395.
Blue Trust first reported a position in IDXX in Q2 2022 and has held it in 18 quarters since. The position peaked at $756K in Q3 2024. 1,115 funds tracked by Wall St. Rank hold IDXX as of Q3 2026.
- Blue Trust held 56 shares of Idexx Laboratories worth $29.2K as of Q3 2026.
- Blue Trust sold 94 Idexx Laboratories shares in Q3 2026, an estimated $51.5K.
- Idexx Laboratories made up ﹤0.01% of Blue Trust's portfolio in Q3 2026, its #1395 holding.
- Blue Trust first reported a position in Idexx Laboratories in Q2 2022 and has held it in 18 quarters since.
- Blue Trust's Idexx Laboratories position peaked at $756K in Q3 2024.
- 1,115 funds tracked by Wall St. Rank held Idexx Laboratories as of Q3 2026.
Based on Blue Trust's 13F filing for Q3 2026, filed 15 Oct 2026.